Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/91/8d/ec/918decb3-bc72-b73c-945a-83dcba50bf1d/mza_792284397039913865.jpg/600x600bb.jpg
Market Lens
Kavout
98 episodes
14 hours ago
Send us a text This episode provide a two-pronged view of Devon Energy, reporting on the company's strong financial and operational performance while also highlighting activist investor involvement. The first source is a press release from Devon Energy announcing their positive third-quarter results for 2025, detailing achievements like exceeding production guidance, generating significant free cash flow, and advancing a $1 billion business optimization target. In contrast, the subsequent sou...
Show more...
Investing
Business
RSS
All content for Market Lens is the property of Kavout and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Send us a text This episode provide a two-pronged view of Devon Energy, reporting on the company's strong financial and operational performance while also highlighting activist investor involvement. The first source is a press release from Devon Energy announcing their positive third-quarter results for 2025, detailing achievements like exceeding production guidance, generating significant free cash flow, and advancing a $1 billion business optimization target. In contrast, the subsequent sou...
Show more...
Investing
Business
https://storage.buzzsprout.com/652jrbtnessoybhq5v6yxb8ey084?.jpg
GLP-1 Drug Stocks Risk: Medicare Deals vs. 2026 Coverage Exclusion
Market Lens
1 minute
1 week ago
GLP-1 Drug Stocks Risk: Medicare Deals vs. 2026 Coverage Exclusion
Send us a text This episode offers conflicting reports regarding the Trump administration's policy on Medicare coverage for GLP-1 drugs used for weight loss. The first source, an article from Investopedia dated November 2025, claims that a new plan would cover popular drugs like Ozempic and Wegovy for Medicare patients for as little as $50 a month, due to negotiated lower prices with pharmaceutical companies. Conversely, the second source, a Pharmaceutical Technology article from April 2025, ...
Market Lens
Send us a text This episode provide a two-pronged view of Devon Energy, reporting on the company's strong financial and operational performance while also highlighting activist investor involvement. The first source is a press release from Devon Energy announcing their positive third-quarter results for 2025, detailing achievements like exceeding production guidance, generating significant free cash flow, and advancing a $1 billion business optimization target. In contrast, the subsequent sou...